MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • 2026 International Congress

    Basal Ganglia Pathway Recruitment Determines Bidirectional Bradykinesia Modulation by DBS in Humans

    P. Navratil, A. Schmidt, H. Eldebakey, N. Rajamani, V. Odekerken, R. de Bie, C. Zhang, K. Kimura, G. Abbas, R. Peach, J. Roothans, J. Volkmann, F. Lange, M. Reich (Wuerzburg, Germany)

    Objective: Understanding the role of distinct basal ganglia pathways in DBS-elicited modulation of bradykinesia across its indications. Background: Opposing bidirectional effects of selective pathway stimulation…
  • 2026 International Congress

    Digital Kinematic Measures of Finger Tapping Detect Dose-Dependent Effects of Deep Brain Stimulation in Parkinson’s Disease

    G. Acevedo, D. Vuddandam, A. Madamangalam, G. Kenworthy, C. Dehemptinne, J. Cagle, J. Wong (Gainesville, USA)

    Objective: To evaluate whether video-based digital kinematic measures can quantify dose-dependent changes in finger tapping performance during deep brain stimulation (DBS) in Parkinson’s disease. Background:…
  • 2026 International Congress

    The Lentiform Fork Sign: Acute Parkinsonism in a Dialysis Patient with Metformin Misuse

    J. Haddad Labello, B. Souza Telho, J. Cavalcanti, R. Bernhart Carra, J. Bezerra Parmera (Sao Paulo, Brazil)

    Objective: To report a rare case of the Lentiform Fork Sign associated with acute parkinsonism in a patient with end-stage renal disease and metformin-associated lactic acidosis. Background: The Lentiform Fork Sign is a rare neuroradiological finding characterized by bilateral T2/FLAIR hyperintensities in the basal ganglia outlining the internal and external capsules (1). It has been most commonly described in patients with end-stage renal disease and is typically associated with metabolic acidosis. The proposed mechanism involves cerebral acidosis leading to vasogenic and/or cytotoxic edema in metabolically vulnerable regions such as the basal ganglia (2). Method: We report a 43-year-old man with end-stage renal disease on hemodialysis and type 2 diabetes mellitus who presented with…
  • 2026 International Congress

    Differential effects of levodopa and subthalamic nucleus deep brain stimulation on the bradykinesia components in Parkinson’s Disease

    D. Marín-Medina, M. Wilken, F. Wainberg, M. Merello (Buenos Aires, Argentina)

    Objective: To quantify and compare the differential effects of DBS and L-dopa on the individual kinematic components of bradykinesia. Background: Parkinson’s disease (PD) bradykinesia is…
  • 2026 International Congress

    Can Prayer Beads Quantify Bradykinesia? An Ultra-Low-Cost Approach to Motor Assessment in Parkinson’s Disease

    N. Raisa, B. Perwirayuda, SB. Rianawati, AC. Pratiwi (Malang, Indonesia)

    Objective: To explore the potential use of portable mechanical counters as a simple approach to quantifying finger movement activity in the evaluation of bradykinesia. Background:…
  • 2026 International Congress

    Microstructural Correlates of Parkinson’s Bradykinesia

    R. Benabderrazik, S. Jasaityte, C. Dore, N. Smith, G. Sheehan, C. Lambert (London, United Kingdom)

    Objective: Define the microstructural correlates of bradykinesia in Parkinson’s disease. Background: Bradykinesia is defined as “slowness of movement”, often associated with decrement, and linked to…
  • 2026 International Congress

    Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

    JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)

    Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…
  • 2026 International Congress

    Characterizing Longitudinal Motor Progression in Parkinson’s Disease leveraging Digital Health Technologies in L-DOPA ON and OFF States

    S. Lambrecht, Y. Gazizova, F. Lipsmeier, W. Popp, B. Fehlmann, T. Nikolcheva, N. Pross, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To characterize the longitudinal motor progression of Parkinson’s disease (PD) over 104 weeks both in practically defined on and off medication states using a…
  • 2026 International Congress

    An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

    Objective: To present the protocol of the Artificial Intelligence-based Parkinson’s Risk Assessment (AI-PRA) study which aims to validate a novel personalised PD risk prediction model…
  • 2026 International Congress

    Motor variability in isolated and probable REM sleep behaviour disorder using remote finger tapping

    H. Chohan, S. Water, L. Pérez-Carbonell, G. Leschziner, T. Periñán, B. Huxford, S. Eriksson, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To determine whether motor impairment and variability extend from isolated REM sleep behaviour disorder (iRBD) to probable RBD (pRBD), and whether instability can be…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley